Tonix Pharmaceuticals

TNXPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$191.768 M

$12.03 +3.26%

Close of 7 Aug 2026

Revenue

$13.1M

#3115 by revenue

Earnings

-$124.0M

Loss-making

Shares outstanding

13,405,401

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#269PepGenPEPG$197.1M
#270ImmunicIMUX$194.8M
#271Tonix PharmaceuticalsTNXP$191.8M
#272Korro BioKRRO$191.1M
#273Lifecore Biomedical, Inc. DeLFCR$189.6M

Where these numbers come from

Share counts and financials for Tonix Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.